NATURALLY-OCCURRING ESCAPE MUTANTS OF HEPATITIS-B VIRUS WITH VARIOUS MUTATIONS IN THE S-GENE IN CARRIERS SEROPOSITIVE FOR ANTIBODY TO HEPATITIS-B SURFACE-ANTIGEN

被引:272
作者
YAMAMOTO, K
HORIKITA, M
TSUDA, F
ITOH, K
AKAHANE, Y
YOTSUMOTO, S
OKAMOTO, H
MIYAKAWA, Y
MAYUMI, M
机构
[1] JICHI MED SCH, DIV IMMUNOL, TOCHIGI 32904, JAPAN
[2] UNIV TOKUSHIMA, SCH MED, DEPT INTERNAL MED 2, TOKUSHIMA 770, JAPAN
[3] VIRAL HEPATITIS RES FDN JAPAN, TOKYO 113, JAPAN
[4] JAPANESE RED CROSS BLOOD CTR, YAMAGATA 753, JAPAN
[5] YAMANASHI MED COLL, DEPT INTERNAL MED 1, YAMANASHI 40938, JAPAN
[6] MITA INST, TOKYO 108, JAPAN
关键词
D O I
10.1128/JVI.68.4.2671-2676.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis B virus (HBV) DNA was extracted from sera of six carriers with hepatitis B e antigen as well as antibody to hepatitis B surface antigen and sequenced within the pre-S regions and the S gene. HBV DNA clones from five of these carriers had point mutations in the S gene, resulting in conversion from Ile-126 or Thr-126 of the wild-type virus to Ser-126 or Asn-126 in three carriers and conversion from Gly-145 to Arg-145 in three of them; clones with Asn-126 or Arg-145 were found in one carrier. All 12 clones from the other carrier had an insertion of 24 bp encoding an additional eight amino acids between Thr-123 and Cys-124. In addition, all or at least some of the HBV DNA clones from these carriers had in-phase deletions in the 5' terminus of the pre-S2 region. These results indicate that HBV escape mutants with mutations in the S gene affecting the expression of group-specific determinants would survive in some carriers after they seroconvert to antibody against surface antigen. Carriers with HBV escape mutants may transmit HBV either by donation of blood units without detectable surface antigen or through community-acquired infection, which would hardly be prevented by current hepatitis B immuneglobulin or vaccines.
引用
收藏
页码:2671 / 2676
页数:6
相关论文
共 31 条
[21]   POLYMERASE CHAIN-REACTION TO DETECT HEPATITIS-B VIRUS-DNA AND RNA SEQUENCES IN PRIMARY LIVER CANCERS FROM PATIENTS NEGATIVE FOR HEPATITIS-B SURFACE-ANTIGEN [J].
PATERLINI, P ;
GERKEN, G ;
NAKAJIMA, E ;
TERRE, S ;
DERRICO, A ;
GRIGIONI, W ;
NALPAS, B ;
FRANCO, D ;
WANDS, J ;
KEW, M ;
PISI, E ;
TIOLLAIS, P ;
BRECHOT, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (02) :80-85
[22]   MUTATIONAL ANALYSIS OF THE HEPATITIS-B VIRUS-P GENE-PRODUCT - DOMAIN-STRUCTURE AND RNASE-H ACTIVITY [J].
RADZIWILL, G ;
TUCKER, W ;
SCHALLER, H .
JOURNAL OF VIROLOGY, 1990, 64 (02) :613-620
[23]   HEPATITIS-B VIRUS GENOMES THAT CANNOT SYNTHESIZE PRE-S2 PROTEINS OCCUR FREQUENTLY AND AS DOMINANT VIRUS POPULATIONS IN CHRONIC CARRIERS IN ITALY [J].
SANTANTONIO, T ;
JUNG, MC ;
SCHNEIDER, R ;
FERNHOLZ, D ;
MILELLA, M ;
MONNO, L ;
PASTORE, G ;
PAPE, GR ;
WILL, H .
VIROLOGY, 1992, 188 (02) :948-952
[24]  
SCHALLER H, 1991, CURR TOP MICROBIOL, V168, P21
[25]  
SCHODEL F, 1992, J VIROL, V66, P106
[26]   DIRECT METHOD FOR QUANTITATION OF EXTREME POLYMERASE ERROR FREQUENCIES AT SELECTED SINGLE BASE SITES IN VIRAL-RNA [J].
STEINHAUER, DA ;
HOLLAND, JJ .
JOURNAL OF VIROLOGY, 1986, 57 (01) :219-228
[27]   REPLICATION OF THE GENOME OF A HEPATITIS-B-LIKE VIRUS BY REVERSE TRANSCRIPTION OF AN RNA INTERMEDIATE [J].
SUMMERS, J ;
MASON, WS .
CELL, 1982, 29 (02) :403-415
[28]  
TAKAHASHI K, 1986, J IMMUNOL, V136, P3467
[29]  
THIERS V, 1988, LANCET, V2, P1273
[30]   THE HEPATITIS-B VIRUS [J].
TIOLLAIS, P ;
POURCEL, C ;
DEJEAN, A .
NATURE, 1985, 317 (6037) :489-495